|
ICMT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.381000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.310800E-01 |
| Normal-vs-Stage2 |
5.726300E-02 |
| Normal-vs-Stage3 |
9.265800E-01 |
| Normal-vs-Stage4 |
6.401400E-01 |
| Stage1-vs-Stage2 |
2.060800E-01 |
| Stage1-vs-Stage3 |
1.734170E-01 |
| Stage1-vs-Stage4 |
8.059600E-02 |
| Stage2-vs-Stage3 |
4.445700E-02 |
| Stage2-vs-Stage4 |
2.266400E-02 |
| Stage3-vs-Stage4 |
5.644600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.765000E-01 |
| Normal-vs-AfricanAmerican |
4.176200E-01 |
| Normal-vs-Asian |
4.039000E-01 |
| Caucasian-vs-AfricanAmerican |
7.224000E-01 |
| Caucasian-vs-Asian |
7.616000E-01 |
| AfricanAmerican-vs-Asian |
9.013000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.263200E-01 |
| Normal-vs-Female |
4.294600E-01 |
| Male-vs-Female |
3.817600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.239200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.804200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.697800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.368000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.727600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.604800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.085800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.445400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.893800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.681000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.238500E-03 |
| Classical-VS-Follicular |
6.759600E-01 |
| Classical-VS-Other |
4.468800E-01 |
| Classical-VS-Normal |
1.319220E-01 |
| Tall-VS-Follicular |
3.339800E-02 |
| Tall-VS-Other |
7.363600E-01 |
| Tall-VS-Normal |
2.527200E-01 |
| Follicular-VS-Other |
6.215400E-01 |
| Follicular-VS-Normal |
3.878800E-01 |
| Other-VS-Normal |
8.963000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.509200E-01 |
| Normal-vs-N1 |
2.655200E-01 |
| N0-vs-N1 |
1.966180E-02 |
|
|
